Carmustine
These highlights do not include all the information needed to use CARMUSTINE FOR INJECTION safely and effectively. See full prescribing information for CARMUSTINE FOR INJECTION. CARMUSTINE for injection, for intravenous use Initial U.S. Approval: 1977
Approved
Approval ID
e6e28c8c-f793-41f3-aaeb-7bf412660288
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 15, 2023
Manufacturers
FDA
Novadoz Pharmaceuticals LLC
DUNS: 081109687
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Carmustine
PRODUCT DETAILS
NDC Product Code72205-198
Application NumberANDA214814
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateNovember 22, 2023
Generic NameCarmustine